Company Overview of Euthymics Bioscience, Inc.
Euthymics Bioscience, Inc., a neuroscience-focused clinical stage company, engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). It provides Amitifadine, an antidepressant for major depressive disorder. The company focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). Euthymics Bioscience, Inc. was founded in 2009 and is based in Cambridge, Massachusetts.
43 Thorndike Street
Cambridge, MA 02141
Founded in 2009
Key Executives for Euthymics Bioscience, Inc.
Similar Private Companies By Industry
|NPIL Pharma, Inc.||United States|
|Daiichi Sankyo, Inc.||United States|
|Chemwerth, Inc.||United States|
|Rapa Holdings Inc.||United States|
|InnoRem, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Euthymics Bioscience, Inc., please visit euthymics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.